Dandan Yu

4.6k total citations
169 papers, 3.2k citations indexed

About

Dandan Yu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Dandan Yu has authored 169 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 87 papers in Molecular Biology, 53 papers in Oncology and 43 papers in Cancer Research. Recurrent topics in Dandan Yu's work include Cancer, Hypoxia, and Metabolism (18 papers), Gastric Cancer Management and Outcomes (13 papers) and MicroRNA in disease regulation (13 papers). Dandan Yu is often cited by papers focused on Cancer, Hypoxia, and Metabolism (18 papers), Gastric Cancer Management and Outcomes (13 papers) and MicroRNA in disease regulation (13 papers). Dandan Yu collaborates with scholars based in China, Norway and United States. Dandan Yu's co-authors include Shanliang Zhong, Jinhai Tang, Jianhua Zhao, Wei‐xian Chen, Zhenyu Lin, Su‐Jin Yang, Yingying Jing, Lixin Wei, Ying Wu and Xiaohui Zhang and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Dandan Yu

164 papers receiving 3.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dandan Yu China 32 1.8k 1.2k 780 403 393 169 3.2k
Dan Cao China 29 1.9k 1.0× 1.2k 1.0× 880 1.1× 385 1.0× 327 0.8× 165 3.5k
Yu‐Shui Ma China 31 1.9k 1.1× 1.3k 1.1× 619 0.8× 218 0.5× 332 0.8× 117 3.0k
Tongsen Zheng China 30 1.8k 1.0× 1.1k 0.9× 876 1.1× 220 0.5× 688 1.8× 63 3.2k
Hao Zhang China 35 2.4k 1.3× 1.1k 0.9× 652 0.8× 684 1.7× 337 0.9× 200 4.0k
Fang Ren China 30 1.4k 0.7× 879 0.7× 449 0.6× 292 0.7× 214 0.5× 139 2.6k
Tommaso A. Dragani Italy 36 2.6k 1.4× 950 0.8× 781 1.0× 344 0.9× 425 1.1× 189 4.2k
Olorunseun O. Ogunwobi United States 29 1.2k 0.6× 1.1k 0.9× 686 0.9× 446 1.1× 188 0.5× 86 2.8k
Kohichi Takada Japan 28 1.7k 0.9× 468 0.4× 854 1.1× 380 0.9× 330 0.8× 172 3.7k
Xiaohua Yan China 30 2.1k 1.1× 588 0.5× 487 0.6× 266 0.7× 309 0.8× 79 3.4k
Soodabeh Shahidsales Iran 28 1.5k 0.8× 949 0.8× 677 0.9× 192 0.5× 195 0.5× 91 2.5k

Countries citing papers authored by Dandan Yu

Since Specialization
Citations

This map shows the geographic impact of Dandan Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dandan Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dandan Yu more than expected).

Fields of papers citing papers by Dandan Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dandan Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dandan Yu. The network helps show where Dandan Yu may publish in the future.

Co-authorship network of co-authors of Dandan Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Dandan Yu. A scholar is included among the top collaborators of Dandan Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dandan Yu. Dandan Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Yu, Dandan, et al.. (2024). Exploring galectin-3’s role in predicting mild cognitive impairment in type 2 diabetes and its regulation by miRNAs. Frontiers in Medicine. 11. 1443133–1443133. 1 indexed citations
3.
Yu, Dandan, Qilin Fan, Linli Shi, et al.. (2024). Gut Roseburia is a protective marker for peritoneal metastasis of gastric cancer. Cancer Medicine. 13(15). e70037–e70037. 4 indexed citations
4.
Zhou, Bin, Dandan Yu, Min Jin, et al.. (2023). Gut Streptococcus is a microbial marker for the occurrence and liver metastasis of pancreatic cancer. Frontiers in Microbiology. 14. 1184869–1184869. 17 indexed citations
5.
Zhang, Hui, Ke Hu, Zhijian Xu, et al.. (2023). A novel pterostilbene compound DCZ0825 induces macrophage M1 differentiation and Th1 polarization to exert anti-myeloma and immunomodulatory. International Immunopharmacology. 127. 111446–111446. 5 indexed citations
6.
Li, Mingjie, Min Jin, Lei Zhao, et al.. (2023). Tumor-associated microbiota in colorectal cancer with vascular tumor thrombus and neural invasion and association with clinical prognosis. Acta Biochimica et Biophysica Sinica. 56(3). 366–378. 3 indexed citations
8.
Xu, Guojie, Lei Zhao, Qingling Hua, et al.. (2023). CEMIP, acting as a scaffold protein for bridging GRAF1 and MIB1, promotes colorectal cancer metastasis via activating CDC42/MAPK pathway. Cell Death and Disease. 14(2). 167–167. 13 indexed citations
9.
Yu, Jiadong, Yu‐Cheng Gu, Dandan Yu, et al.. (2023). Two New Cembranoids from the Chinese Soft Coral Sarcophyton boettgeri**. Chemistry & Biodiversity. 20(7). e202300662–e202300662. 3 indexed citations
10.
Yu, Dandan, Hui Luo, Li‐Gong Yao, et al.. (2023). Oxygenated Cembrane Diterpenes from the South China Sea Soft Coral Sinularia tumulosa**. Chemistry & Biodiversity. 20(7). e202300589–e202300589. 4 indexed citations
11.
Yu, Dandan, Mengzhu Zheng, Yang Liu, Lixia Chen, & Hua Li. (2022). Proteolysis-Targeting Chimera Molecules Targeting SHP2. Future Medicinal Chemistry. 14(8). 587–600. 6 indexed citations
12.
Hua, Qingling, Biying Zhang, Guojie Xu, et al.. (2021). CEMIP, a novel adaptor protein of OGT, promotes colorectal cancer metastasis through glutamine metabolic reprogramming via reciprocal regulation of β-catenin. Oncogene. 40(46). 6443–6455. 41 indexed citations
13.
Jiang, Zhaoqiang, Jing Wang, Lingfang Feng, et al.. (2019). Menstrual disorders and occupational exposures among female nurses: A nationwide cross-sectional study. International Journal of Nursing Studies. 95. 49–55. 18 indexed citations
14.
Chen, Danlei, Rui Cao, Dandan Yu, et al.. (2018). Alcohol consumption promotes colorectal carcinoma metastasis via a CCL5-induced and AMPK-pathway-mediated activation of autophagy. Scientific Reports. 8(1). 8640–8640. 19 indexed citations
15.
Zhang, Yiwen, Dandan Yu, & Fenghuang Zhan. (2017). Checkpoint inhibition in myeloma. 26(2). 78–82. 1 indexed citations
16.
Zhong, Shanliang, Lin Chen, Xiaohui Zhang, et al.. (2015). Aspirin Use and Risk of Breast Cancer: Systematic Review and Meta-analysis of Observational Studies. Cancer Epidemiology Biomarkers & Prevention. 24(11). 1645–1655. 38 indexed citations
17.
Woodside, Jayne V., Margaret Ashwell, C. Edwards, et al.. (2014). NRR volume 27 issue 1 Cover and Front matter. Nutrition Research Reviews. 27(1). f1–f5. 1 indexed citations
18.
Cai, Yunlang, Jingmei Wang, Di Wu, et al.. (2014). Expressions of fatty acid synthase and HER2 are correlated with poor prognosis of ovarian cancer. Medical Oncology. 32(1). 391–391. 101 indexed citations
19.
He, Jianrong, Lu-Ying Tang, Dandan Yu, et al.. (2011). Epstein-Barr virus and breast cancer: Serological study in a high-incidence area of nasopharyngeal carcinoma. Cancer Letters. 309(2). 128–136. 43 indexed citations
20.
Yu, Dandan. (2005). Clinical Study of Guilu Erxianjiao Decoction in Treating Knee Osteoarthritis. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026